Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-24-126625)

Filing Details

Accession Number:: 0000950170-24-126625
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-13 20:06:03
Reporting Period:: 2024-11-11

Accepted Time:: 2024-11-13 20:06:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323113	Jr N Daniel Swisher	C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-11	2,200	$12.13	2,200	No	4	M	Direct
Common Stock	Disposition	2024-11-11	2,200	$59.88	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2024-11-11	2,200	$0.00	2,200	$12.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,800		2027-05-24	No	4	M	Direct

Footnotes

The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
Fully exercisable.
The Reporting Person previously transferred 15,000 shares underlying the stock option to his ex-spouse. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.